Emergent BioSolutions Inc. (NYSE:EBS) announced today that the company
will be presenting at the BMO Capital Markets “Focus
on Healthcare Conference” on Wednesday August
6, 2008 at 11:15 AM Eastern. A member of the company’s
senior management team will provide a corporate overview, including a
discussion of product development programs, recent corporate activities
and past financial performance.
A webcast of this presentation will be available both live and by
replay. To access either the live or archived webcast, please proceed to www.emergentbiosolutions.com,
and click on the “Investors”
link the day of the presentation.
An archived replay of the webcast will be available 24 hours after the
live presentation.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc. is a leading biopharmaceutical company
dedicated to one simple mission—to protect
life. Emergent develops, manufactures and commercializes vaccines
and therapeutics that assist the body’s immune
system to prevent or treat disease. Emergent’s
products target infectious diseases and other medical conditions that
have resulted in significant unmet or underserved public health needs.
The company’s marketed product, BioThrax®
(Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S.
Food and Drug Administration for the prevention of anthrax infection. www.emergentbiosolutions.com.
Emergent BioSolutions Inc.
Investors Contact:
Robert G.
Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media
Contact:
Tracey Schmitt
Director, Corporate Communications
301-795-1800
SchmittT@ebsi.com
